WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
US Federal officials have approved a new pain pill by Vertex Pharmaceuticals called Journavx, aimed at reducing addiction and ...
House Republicans plan to introduce a bill that would officially designate several major Mexican drug cartels as foreign terrorist organizations (FTOs), legislation that would make President Donald ...
A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug Administration (FDA). The drug suzetrigine, known by its brand name Journavx ...
US regulators approve new type of pain drug designed to eliminate the risks of addiction associated with opioids.
The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...
The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback